📢 Press Release – Qinecsa Solutions announce the acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions.
Qinecsa Solutions is delighted to share the news of the acquisition of Insife, a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms.
John Gillie, CEO of Qinecsa Solutions, expressed: “We are thrilled to welcome Insife into the Qinecsa family. This acquisition marks a significant milestone, reinforcing our position as a unique pharmacovigilance provider. Together, we are poised to deliver even greater value and support to our customers globally."
Martin Holm-Petersen, CEO of Insife, highlighted: “Joining forces with Qinecsa is a strategic move that benefits our company, its people, and our clients. Together, we will expand our global footprint, drive positive outcomes for the pharmaceutical industry, and underline our position as the number one technology provider for pharmacovigilance."
🌍 This strategic move aligns perfectly with Qinecsa's vision, reinforcing our commitment to delivering cutting-edge end-to-end pharmacovigilance solutions and solidifying our position as a global leader in digital pharmacovigilance.
Exciting and promising future for Qinecsa and Insife by joining forces to advance patient safety, drug development, and regulatory compliance through AI-driven technologies and cutting-edge solutions. 🌟
To read the full press release, please visit: https://lnkd.in/dqvzKYH3.
For any inquiries, please contact us contact@qinecsa.com
#Insife #Qinecsa #Pharmacovigilance #Innovation #PatientSafety #Tech #HALOPV